Medscape7h
Drug Labels Often Neglect to Inform About Obesity Dosing
Obesity and pharmacology experts are warning about hidden safety risks and efficacy issues for many types of medications in ...
DexCom price target raised to $104 from $101 at Citi
Citi raised the firm’s price target on DexCom (DXCM) to $104 from $101 and keeps a Buy rating on the shares. The firm adjusted medical ...
Dexcom (DXCM) Receives a Buy from Citi
In a report released yesterday, Joanne Wuensch from Citi reiterated a Buy rating on Dexcom (DXCM – Research Report), with a price target of ...